Chiome Bioscience Inc.
4583.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥1,006 | ¥1,475 | ¥1,819 | ¥2,063 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥78 | ¥55 | ¥54 | ¥51 |
| Inventory | ¥53 | ¥47 | ¥48 | ¥46 |
| Other Curr. Assets | ¥120 | ¥149 | ¥53 | ¥131 |
| Total Curr. Assets | ¥1,362 | ¥1,830 | ¥2,076 | ¥2,338 |
| Property Plant & Equip (Net) | ¥39 | ¥0 | ¥0 | ¥0 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥0 | ¥0 | ¥0 | ¥0 |
| Long-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Tax Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Assets | ¥148 | ¥132 | ¥128 | ¥131 |
| Total NC Assets | ¥187 | ¥132 | ¥128 | ¥131 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥1,549 | ¥1,963 | ¥2,205 | ¥2,469 |
| Liabilities | – | – | – | – |
| Payables | ¥35 | ¥37 | ¥30 | ¥27 |
| Short-Term Debt | ¥79 | ¥261 | ¥282 | ¥282 |
| Tax Payable | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Revenue | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Curr. Liab. | ¥122 | ¥80 | ¥72 | ¥155 |
| Total Curr. Liab. | ¥244 | ¥388 | ¥388 | ¥493 |
| LT Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Liab. | ¥55 | ¥55 | ¥55 | ¥55 |
| Total NC Liab. | ¥55 | ¥55 | ¥55 | ¥55 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liabilities | ¥299 | ¥443 | ¥443 | ¥549 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥1,066 | ¥1,066 | ¥1,049 | ¥996 |
| Retained Earnings | -¥1,821 | -¥1,561 | -¥1,287 | -¥1,021 |
| AOCI | ¥0 | ¥9 | ¥9 | ¥10 |
| Other Equity | ¥0 | ¥0 | -¥0 | ¥0 |
| Total Equity | ¥1,250 | ¥1,519 | ¥1,761 | ¥1,920 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥1,549 | ¥1,963 | ¥2,205 | ¥2,469 |
| Net Debt | -¥926 | -¥1,214 | -¥1,537 | -¥1,782 |